RAF1 and melanoma: Examination of MEK, the upstream activator of ERK, showed a similar pattern of inactivation and activation in response to PLX4032 (Figure 2, pMEK), demonstrating that while the RAF-MEK-ERK pathway was inhibited in BRAF mutants, it was activated in BRAFwt melanoma cells.